ea0073ep217 | Thyroid | ECE2021
Mazurina Natalya
, Glibka Anastasiya
, Troshina Ekaterina
, Laktionov Konstantine
, Kharkevich Galina
, Sarantseva Kseniya
, Kruteleva Svetlana
IntroductionProspective and retrospective trials report the incidence of endocrine adverse events provoked by immune checkpoint inhibitors (ICI) up to 30%. PD-1/PDL inhibitors have a higher incidence of thyroid dysfunction: hypothyroidism 5%-14%, transient hyperthyroidism 3%-5%.The aim of the study was to assess thyroid function in PD-1/PDL treated patients.Materials and methods6...